Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors

Sustained cardiac hypertrophy represents one of the most common causes leading to cardiac failure. There is emerging evidence to implicate the involvement of NF-κB in the development of cardiac hypertrophy. However, several critical questions remain unanswered. We tested the use of soluble epoxide h...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Xu, Danyan, Li, Ning, He, Yuxia, Timofeyev, Valeriy, Lu, Ling, Tsai, Hsing-Ju, Kim, In-Hae, Tuteja, Dipika, Mateo, Robertino Karlo P., Singapuri, Anil, Davis, Benjamin B., Low, Reginald, Hammock, Bruce D., Chiamvimonvat, Nipavan
Materialtyp: Artigo
Språk:Inglês
Publicerad: National Academy of Sciences 2006
Ämnen:
Biological Sciences
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1693731/
https://ncbi.nlm.nih.gov/pubmed/17130447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0609158103
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk